Cargando…

Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis

BACKGROUND: Diagnostics provide a means to measure progress toward disease elimination. Many countries in Africa are approaching elimination of onchocerciasis after successful implementation of mass drug administration programs as well as vector control. An understanding of how markers for infection...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golden, Allison, Faulx, Dunia, Kalnoky, Michael, Stevens, Eric, Yokobe, Lindsay, Peck, Roger, Karabou, Potochoziou, Banla, Méba, Rao, Ramakrishna, Adade, Kangi, Gantin, Richard G., Komlan, Kossi, Soboslay, Peter T., de los Santos, Tala, Domingo, Gonzalo J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907250/ https://www.ncbi.nlm.nih.gov/pubmed/27296630 http://dx.doi.org/10.1186/s13071-016-1623-1

Ejemplares similares

A Recombinant Positive Control for Serology Diagnostic Tests Supporting Elimination of Onchocerca volvulus
por: Golden, Allison, et al.
Publicado: (2016)

Sustainable Control of Onchocerciasis: Ocular Pathology in Onchocerciasis Patients Treated Annually with Ivermectin for 23 Years: A Cohort Study
por: Banla, Méba, et al.
Publicado: (2014)

Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin
por: Komlan, Kossi, et al.
Publicado: (2018)

Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo
por: Johanns, Saskia I., et al.
Publicado: (2022)

Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo
por: Korbmacher, Francois, et al.
Publicado: (2018)

Feasibility of utilizing the SD BIOLINE Onchocerciasis IgG4 rapid test in onchocerciasis surveillance in Senegal
por: Dieye, Yakou, et al.
Publicado: (2017)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes
por: Lont, Yvonne L., et al.
Publicado: (2017)

Cytokine and chemokine responses to helminth and protozoan parasites and to fungus and mite allergens in neonates, children, adults, and the elderly
por: Lechner, Christian J, et al.
Publicado: (2013)

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
por: Dusabimana, Alfred, et al.
Publicado: (2020)

Tandem Use of OvMANE1 and Ov-16 ELISA Tests Increases the Sensitivity for the Diagnosis of Human Onchocerciasis
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2021)

Concordance between Ov16 rapid diagnostic test(RDT) and Ov16 enzyme-linked immunosorbent assay (ELISA) for the diagnosis of onchocerciasis in areas of contrasting endemicity in cameroon
por: Ekanya, Relindis, et al.
Publicado: (2023)

Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus
por: Luz, Sérgio Luiz Bessa, et al.
Publicado: (2014)

In Silico Design and Validation of OvMANE1, a Chimeric Antigen for Human Onchocerciasis Diagnosis
por: Shintouo, Cabirou Mounchili, et al.
Publicado: (2020)

Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring
por: Yengo, Bernis Neneyoh, et al.
Publicado: (2022)

Co-Administration of Adjuvanted Recombinant Ov-103 and Ov-RAL-2 Vaccines Confer Protection against Natural Challenge in A Bovine Onchocerca ochengi Infection Model of Human Onchocerciasis
por: Luu, Lisa, et al.
Publicado: (2022)

Prise en charge et résultats fonctionnels des cataractes traumatiques dans la région centrale du Togo
por: Saa, Kassoula Batomaguela Nonon, et al.
Publicado: (2016)

Changes in Onchocerciasis Ov16 IgG4 Rapid Diagnostic Test Results Over One-Month Follow-up: Lessons for Reading Timeframe and Decision-Making
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2022)

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening
por: Dusabimana, Alfred, et al.
Publicado: (2022)

Extended Result Reading Window in Lateral Flow Tests Detecting Exposure to Onchocerca volvulus: A New Technology to Improve Epidemiological Surveillance Tools
por: Golden, Allison, et al.
Publicado: (2013)

Diagnostics for onchocerciasis in the era of elimination
por: Unnasch, Thomas R, et al.
Publicado: (2018)

Ov2 is a modulator of OvHV-2 RTA mediated gene expression
por: Dry, Inga, et al.
Publicado: (2019)

Nouveau coronavirus (NcOV)
por: Bricaire, François
Publicado: (2013)

Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy
por: Djune-Yemeli, Linda, et al.
Publicado: (2022)

Evaluation of glycoprotein Ov8 as a potential antigen for an OvHV-2-specific diagnostic assay
por: Alhajri, Salim M., et al.
Publicado: (2018)

Deletion of gene OV132 attenuates Orf virus more effectively than gene OV112
por: Yamada, Yumiko, et al.
Publicado: (2022)

Risk factors for Mycobacterium ulcerans infection (Buruli Ulcer) in Togo ─ a case-control study in Zio and Yoto districts of the maritime region
por: Maman, Issaka, et al.
Publicado: (2018)

Facteurs de risque du décollement de rétine au Togo
por: Maneh, Nidain, et al.
Publicado: (2017)

Onchocerciasis
Publicado: (1911)

Evaluation of onchocerciasis seroprevalence in Bioko Island (Equatorial Guinea) after years of disease control programmes
por: Hernández-González, Ana, et al.
Publicado: (2016)

Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281
por: Dusabimana, Alfred, et al.
Publicado: (2022)

The NR3B subgroup: an ovERRview
por: Tremblay, Annie M., et al.
Publicado: (2007)

Les conjonctivites néonatales dans le canton de Glidji au Sud du Togo: une étude transversale à propos de 159 nouveau-nés
por: Kokou, Vonor, et al.
Publicado: (2016)

The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice
por: Hess, Jessica A., et al.
Publicado: (2016)

2) Onchocerciasis
por: Tada, Isao
Publicado: (2015)

3) Onchocerciasis
por: Tada, Isao
Publicado: (2015)

Navigating the way to onchocerciasis elimination: the feasibility and affordability of Onchocerciasis Elimination Mapping
por: Hamill, Louise, et al.
Publicado: (2022)

Regulation of Ov2 by virus encoded microRNAs
por: Nightingale, Katie, et al.
Publicado: (2019)

Cellular cytokine and chemokine responses to parasite antigens and fungus and mite allergens in children co-infected with helminthes and protozoa parasites
por: Hegewald, Jana, et al.
Publicado: (2015)

Information for onchocerciasis control
por: Hopkins, Adrian
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_02cv3tj3jg17kegtju84tducna